Page last updated: 2024-08-25

doripenem and Chemotherapy-Induced Febrile Neutropenia

doripenem has been researched along with Chemotherapy-Induced Febrile Neutropenia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aoki, Y; Fujishima, Y; Hanamura, I; Ishida, Y; Ito, S; Kowata, S; Mine, T; Oyake, T; Sugawara, N; Takemasa-Fujisawa, Y; Tsukushi, Y	1

Trials

1 trial(s) available for doripenem and Chemotherapy-Induced Febrile Neutropenia

Article	Year
Doripenem versus meropenem as first-line empiric therapy of febrile neutropenia in patients with acute leukemia: a prospective, randomized study. Annals of hematology, 2019, Volume: 98, Issue:5 Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Chemotherapy-Induced Febrile Neutropenia; Doripenem; Female; Fever; Humans; Leukemia; Male; Meropenem; Middle Aged; Myelodysplastic Syndromes; Prospective Studies	2019

Article

Year

Doripenem versus meropenem as first-line empiric therapy of febrile neutropenia in patients with acute leukemia: a prospective, randomized study.

Annals of hematology, 2019, Volume: 98, Issue:5

Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Chemotherapy-Induced Febrile Neutropenia; Doripenem; Female; Fever; Humans; Leukemia; Male; Meropenem; Middle Aged; Myelodysplastic Syndromes; Prospective Studies

2019